Xiaohui Liu

State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.

Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.

Journal: The Pediatric infectious disease journal

Published: February 18, 2026

Long-term protection from naturally acquired immunity against hepatitis E virus reinfection.

Long-term protection from naturally acquired immunity against hepatitis E virus reinfection.

Journal: Nature communications

Published: July 29, 2025

A ligand oxidation structure-adaptive strategy for copper passivation.

A ligand oxidation structure-adaptive strategy for copper passivation.

Journal: Nature communications

Published: November 11, 2024

Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study.

Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study.

Journal: Nature communications

Published: September 01, 2024

A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years.

A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years.

Journal: NPJ vaccines

Published: July 09, 2024

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: July 21, 2023

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The Lancet. Respiratory medicine

Published: May 31, 2023

Cancer metastasis is related to normal tissue stemness.

Cancer metastasis is related to normal tissue stemness.

Journal: PloS one

Published: April 25, 2022

Diblock Copolymers Containing Titanium-Hybridized Polyhedral Oligomeric Silsesquioxane Used as a Macromolecular Flame Retardant for Epoxy Resin.

Diblock Copolymers Containing Titanium-Hybridized Polyhedral Oligomeric Silsesquioxane Used as a Macromolecular Flame Retardant for Epoxy Resin.

Journal: Polymers

Published: March 14, 2022

The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.

The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.

Journal: Emerging microbes & infections

Published: February 23, 2022

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.

Journal: Science bulletin

Published: February 21, 2022

Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective.

Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective.

Journal: Frontiers in microbiology

Published: December 04, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026